- Home
- LEXX vs SMSI Comparison
LEXX vs SMSI Comparison
Compare LEXX & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- SMSI
- Stock Information
- Founded
- LEXX 2004
- SMSI 1982
- Country
- LEXX Canada
- SMSI United States
- Employees
- LEXX N/A
- SMSI 164
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- LEXX Health Care
- SMSI Technology
- Exchange
- LEXX Nasdaq
- SMSI Nasdaq
- Market Cap
- LEXX 20.9M
- SMSI 15.9M
- IPO Year
- LEXX N/A
- SMSI 1995
- Fundamental
- Price
- LEXX $0.98
- SMSI $0.79
- Analyst Decision
- LEXX Strong Buy
- SMSI Strong Buy
- Analyst Count
- LEXX 1
- SMSI 1
- Target Price
- LEXX $7.00
- SMSI $5.00
- AVG Volume (30 Days)
- LEXX 90.9K
- SMSI 138.7K
- Earning Date
- LEXX 07-11-2025
- SMSI 05-07-2025
- Dividend Yield
- LEXX N/A
- SMSI N/A
- EPS Growth
- LEXX N/A
- SMSI N/A
- EPS
- LEXX N/A
- SMSI N/A
- Revenue
- LEXX $525,923.00
- SMSI $19,378,000.00
- Revenue This Year
- LEXX $0.62
- SMSI $31.76
- Revenue Next Year
- LEXX $14.19
- SMSI $44.43
- P/E Ratio
- LEXX N/A
- SMSI N/A
- Revenue Growth
- LEXX 29.95
- SMSI N/A
- 52 Week Low
- LEXX $0.95
- SMSI $0.52
- 52 Week High
- LEXX $4.44
- SMSI $2.57
- Technical
- Relative Strength Index (RSI)
- LEXX 38.55
- SMSI 43.48
- Support Level
- LEXX $1.00
- SMSI $0.80
- Resistance Level
- LEXX $1.05
- SMSI $0.86
- Average True Range (ATR)
- LEXX 0.05
- SMSI 0.06
- MACD
- LEXX 0.01
- SMSI -0.01
- Stochastic Oscillator
- LEXX 28.80
- SMSI 34.85
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.